Clin2
NCT02785380Possibly a fitNot yet recruiting

Laparoscopic surgery vs RFA for recurrent liver cancer

Hepatocellular Carcinoma

Part of Cancer, Digestive system clinical trials.

This study compares two ways to remove a recurrence of liver cancer: laparoscopic surgery (small belly cuts) versus RFA (a heat treatment through a needle). It aims to see which option works better for people with a limited-size, limited-location recurrence and good liver function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
340 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old
  • You have liver cancer (HCC) that came back after a previous curative liver surgery
  • Your recurrent tumor is small and limited: either one spot up to 3 cm, or up to 3 spots each up to 3 cm
  • The spot is in specific liver areas (left outer part/segments II–III) or very near the liver surface edge (within 1 cm)
  • Scans do not show spread into major liver veins/portal vein branches or outside the liver
  • Your liver function is in a good range (Child-Pugh class A or B)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06577272Recruiting
Predicting cancer return after tumor ablation

This study looks at people with liver cancer who are treated with a procedure called radiofrequency ablation (RFA). It aims to create a tool that can predict the chance of the cancer coming back after treatment.

Hangzhou, Zhejiang
NCT04365751Recruiting
Microwave ablation versus surgery for liver cancer

This trial compares two ways to treat hepatocellular carcinoma (a type of liver cancer): microwave ablation and laparoscopic hepatectomy (keyhole liver surgery). It may help find which option works better for tumor control and recovery in people with limited, non-spread cancer.

Beijing, Beijing Municipality
NCT06498622Recruiting· Phase 2
Liver cancer relapse prevention after surgery

This trial tests a combination of two drugs (Donafenib and Envafolimab) after surgery to lower the risk of liver cancer coming back in people who have high-risk features. It may help if you qualify based on your tumor(s) and overall health.

Fuyang, Anhui
NCT07594340Recruiting· Phase 3
Advanced Liver Cancer Treatment Comparison Study

This study compares two treatment approaches for advanced liver cancer that has spread within the liver but not to other parts of the body. Both treatments combine chemotherapy delivered directly to the liver with immunotherapy drugs to help your immune system fight the cancer.

Guangzhou, Guangdong
NCT05492136Recruiting
Radiofrequency during liver surgery to reduce cancer coming back

This study looks at whether using radiofrequency (a heat-based treatment used during surgery) during liver surgery can lower the chances that cancer returns locally. It includes people with colorectal cancer that has spread to the liver and people with liver cancer (HCC).

Barcelona
NCT06766643Recruiting· Phase 2
Stereotactic radiosurgery vs. radiofrequency ablation for liver cancer

This study compares two nonsurgical procedures for liver cancer: stereotactic radiosurgery (focused radiation) and radiofrequency ablation (heat therapy). It is for people whose tumor is in a tricky spot near major blood vessels or other structures, making surgery difficult, and who have not received prior treatment.

Tianjin

Hear when a new Hepatocellular Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.